Course for Interventionists in training 2015

The 6th edition of ProEducar-SOLACI Course was held as a pre-conference activity at SOLACI-SOCIME ’15 – August 4, 2015 at Hotel Camino Real Polanco – Mexico DF.

This course is intended for on-training interventionist from Latin America with the purpose of strengthening existing educational programs and the integration to establish a forum for them. For queries and information write to proeducar@solaci.org

More information in the Congress official website 

More articles by this author

See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition...

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

13th ProEducar-SOLACI Fellows Course Held at SOLACI-SBHCI 2023

ProEducar-SOLACI Fellows Course continues to grow! For the thirteenth consecutive year, the traditional SOLACI course for fellow interventionists was held at SOLACI-SBHCI 2023. The course...

Teve lugar o 13º Curso de Fellows do ProEducar-SOLACI no Congresso SOLACI-SBHCI 2023

o Curso de Fellows do ProEducar-SOLACI continua crescendo! Pelo décimo terceiro ano consecutivo teve lugar o tradicional Curso da SOLACI para intervencionistas em formação...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...